07:40 AM EST, 11/06/2025 (MT Newswires) -- Moderna ( MRNA ) reported a Q3 net loss Thursday of $0.51 per share, swinging from earnings of $0.03 a year earlier.

Analysts polled by FactSet expected a loss of $2.

Total revenue for the quarter ended Sept. 30 was $1.02 billion, down from $1.86 billion a year earlier.

Analysts surveyed by FactSet expected $879.6 billion.

The company said it now expects 2025 revenue in the range of $1.6 billion to $2 billion, compared with its prior range of $1.5 billion to $2.2 billion. Analysts polled by FactSet expect $1.89 billion.

Moderna's ( MRNA ) stock was up 5.5% in recent Thursday premarket activity.